| | GIMAP1-GIMAP5, GIMAP5 (E299Q +2 more) | Single nucleotide variant (missense variant) | not specified | |
| | GIMAP1-GIMAP5, GIMAP5 (S157T +1 more) | Single nucleotide variant (missense variant +1 more) | not specified | |
| | GIMAP1-GIMAP5, GIMAP5 (L149V +2 more) | Single nucleotide variant (missense variant) | EBV-positive nodal T- and NK-cell lymphoma | |
| | | Single nucleotide variant (synonymous variant) | not provided | |
| | GIMAP1-GIMAP5, GIMAP5 (L18F +1 more) | Single nucleotide variant (missense variant +1 more) | not specified | |
| | GIMAP5, GIMAP1-GIMAP5 (R254Q +2 more) | Single nucleotide variant (missense variant) | not specified | |
| | GIMAP1-GIMAP5, GIMAP5 (R40K +1 more) | Single nucleotide variant (missense variant +1 more) | not specified | |
| | GIMAP1-GIMAP5, GIMAP5 (R382W +2 more) | Single nucleotide variant (missense variant) | not specified | |
| | GIMAP1-GIMAP5, GIMAP5 (V151I +1 more) | Single nucleotide variant (missense variant +1 more) | not specified | |
| | GIMAP1-GIMAP5, GIMAP5 (D67E +1 more) | Single nucleotide variant (missense variant +1 more) | not specified | |
| | GIMAP1-GIMAP5, GIMAP5 (G54R +1 more) | Single nucleotide variant (missense variant +1 more) | not specified | |
| | GIMAP1-GIMAP5, GIMAP5 (P109L +2 more) | Single nucleotide variant (missense variant) | Portal hypertension, noncirrhotic, 2 +1 more | GPathogenic/Likely pathogenic |
| | GIMAP1-GIMAP5, GIMAP5 (L223F +2 more) | Single nucleotide variant (missense variant) | Portal hypertension, noncirrhotic, 2 +1 more | GPathogenic/Likely pathogenic |
| | GIMAP5, GIMAP1-GIMAP5 (I123T +2 more) | Single nucleotide variant (missense variant) | Portal hypertension, noncirrhotic, 2 +1 more | GPathogenic/Likely pathogenic |
| | GIMAP1-GIMAP5, GIMAP5 (L280P +1 more) | Single nucleotide variant (missense variant) | Portal hypertension, noncirrhotic, 2 +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant) | not provided | |